ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,733.50
-0.44%
S&P ASX All Technology
3,073.30
-2.06%
Brent Oil
85.375
0.31%
US Dollar vs AUD
1.49994
0.10%
Bitcoin
63,366.05
1.11%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Orphazyme AS (ORPH)

  7. Orphazyme AS (ORPH) News

ORPH

Orphazyme AS (ORPH)

Orphazyme AS
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORPH
DateTimeSourceHeadlineSymbolCompany
10/02/202323:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORPHOrphazyme AS
09/06/202220:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
24/05/202206:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
17/05/202206:31Edgar (US Regulatory)Amended Notification That Form 20-f Will Be Submitted Late (nt 20-f/a)NASDAQ:ORPHOrphazyme AS
17/05/202206:27Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
16/05/202222:39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
29/04/202221:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
29/04/202221:40Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
07/04/202220:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
06/04/202220:40Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
05/04/202207:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
01/04/202221:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
01/04/202208:42Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ORPHOrphazyme AS
01/04/202206:17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
29/03/202222:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
24/03/202221:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ORPHOrphazyme AS
22/03/202223:02Dow Jones NewsOrphazyme Begins Delisting ADSs From NasdaqNASDAQ:ORPHOrphazyme AS
22/03/202221:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
22/03/202207:24Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:ORPHOrphazyme AS
18/03/202223:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
11/03/202209:12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
03/03/202223:44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
24/02/202222:27Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
19/02/202208:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
15/02/202208:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
11/02/202223:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
04/02/202208:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORPHOrphazyme AS
01/02/202204:45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
25/01/202222:25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
19/01/202222:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
 Showing the most relevant articles for your search:NASDAQ:ORPH

Your Recent History

NASDAQ
ORPH
Orphazyme AS
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved